We report the case of a neonate who likely developed symptoms of Neonatal Abstinence Syndrome after in-utero exposure to gabapentin for treatment of maternal chronic pain. The neonate developed symptoms of hypertonicity, tremor, and poor feeding twelve hours after delivery. Altho...
Open access
Research Article10.9734/IJMPCR/2015/17253
We report the use of Gabapentin (Neurontin), an anticonvulsant and analgesic, as a non-opioid adjunct agent in the treatment of a term newborn infant with neonatal abstinence syndrome (NAS). Initial treatment with methadone to prevent withdrawal symptoms was not fully effective....
Open access
Research Article10.9734/IJMPCR/2015/16142
Aims: To present a novel method of securing nasogastric (NGT) feeding tubes in pediatric burn patients. Presentation of Case: We have developed an arrangement of tube, twill tie and suture, to secure a feeding tube in position, in which a twill tie is secured around the patient’s...
Open access
Research Article10.9734/BJMMR/2015/13729
We present the case of a 6-week-old male infant with Neonatal Abstinence Syndrome (NAS) in which DonnatalTM (phenobarbital, hyoscyamine, atropine, hyoscine) Elixir was used as an adjunct therapy. The infant was born to a mother taking 130mg of methadone per day since conception....
Open access
Research Article10.9734/BJMMR/2014/12419
A 2,600-gram infant treated with methadone and clonidine for Neonatal Abstinence Syndrome (NAS) developed acute hypertension following initiation of the clonidine taper, requiring treatment with a calcium channel blocker. While transient hypertension after discontinuing alpha-2 a...
Open access
Research Article10.9734/IJMPCR/2016/29918